M1 Kliniken AG

FSX:M12.DE

16.5 (EUR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q4
Revenue 167.741165.507150.793146.623138.668149.731164.88130.46129.1344.28432.93236.28228.92724.93822.25717.45718.49824.76610.168.7325.7545.7545.7545.754
Cost of Revenue 145.038150.887137.874134.426125.093136.546150.577119.124.87537.67223.96329.18822.51320.39215.65114.89216.8516.4619.6986.1474.9354.9354.9354.935
Gross Profit 22.70314.6212.91912.19713.57513.18514.30211.3614.2556.6128.9697.0946.4144.5456.6062.5651.6488.3050.4622.5840.8190.8190.8190.819
Gross Profit Ratio 0.1350.0880.0860.0830.0980.0880.0870.0870.1460.1490.2720.1960.2220.1820.2970.1470.0890.3350.0450.2960.1420.1420.1420.142
Reseach & Development Expenses 000000000000000000000000
General & Administrative Expenses 000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000
SG&A 6.0347.6835.858.0759.8328.5267.7068.7753.0912.1475.7662.46501.899000000.4940.2110.2110.2110.211
Other Expenses 8.229-300.810.210.7530.730.4090.4710.5750.08-1.1781.4420000000000000
Operating Expenses 8.229300.815.647.3229.1038.1187.2358.1993.0123.3264.3234.1092.9392.9952.4531.2521.3971.0980.6550.4940.2110.2110.2110.211
Operating Income 14.474-135.3037.2794.8754.4725.0677.0673.1621.2433.2874.6462.9193.4751.3934.1531.3123.0476.81-0.2421.761.2581.2581.2581.258
Operating Income Ratio 0.086-0.8180.0480.0330.0320.0340.0430.0240.0430.0740.1410.080.120.0560.1870.0750.1650.275-0.0240.2020.2190.2190.2190.219
Total Other Income Expenses Net 0.544144.725-0.3111.297-1.2660.1850.8970.440.5384.2750.5370.8870.8131.730.0771.0720.0520.29-0.09-0.067-0.051-0.051-0.051-0.051
Income Before Tax 15.0189.4226.9696.1733.2065.2527.9653.6021.7817.5625.1833.8074.2883.1244.232.3843.0997.1-0.3321.6931.2081.2081.2081.208
Income Before Tax Ratio 0.090.0570.0460.0420.0230.0350.0480.0280.0610.1710.1570.1050.1480.1250.190.1370.1680.287-0.0330.1940.210.210.210.21
Income Tax Expense 4.4559.4222.841.9011.2631.0622.4820.8670.4861.8361.180.5680.9151.0340.5420.270.2060.0780.060.0350.0610.0610.0610.061
Net Income 9.96.8573.4172.9391.3795.4953.4114.7862.0375.7264.0033.2393.3732.093.6882.1142.8937.022-0.3921.6581.1461.1461.1461.146
Net Income Ratio 0.0590.0410.0230.020.010.0370.0210.0370.070.1290.1220.0890.1170.0840.1660.1210.1560.284-0.0390.190.1990.1990.1990.199
EPS 0.530.380.190.160.0740.30.180.260.10.330.230.190.20.130.250.140.190.47-0.0260.110.0760.0760.0760.076
EPS Diluted 0.530.380.190.160.0740.30.180.260.10.330.230.190.20.130.250.140.190.47-0.0260.110.0760.0760.0760.076
EBITDA 16.971-135.3039.9478.0497.3617.9579.8665.9432.9465.3865.9483.3753.731.6624.3461.5053.1426.951-0.1641.8151.2861.2861.2861.286
EBITDA Ratio 0.101-0.8180.0660.0550.0530.0530.060.0460.1010.1220.1810.0930.1290.0670.1950.0860.170.281-0.0160.2080.2230.2230.2230.223